A revolutionary oncology company, targeting tumours through unique technologies.
Incanthera is committed to the development of novel treatments for solid tumours (cancers), and licensing these to large pharmaceutical companies. Operating from Manchester, with research facilities in Bradford and Salford, Incanthera Ltd was established from the University of Bradford’s Institute of Cancer Therapeutics (www.cancer.brad.ac.uk).
The company is a spin-out from Bradford University’s Institute of Cancer Therapeutics
Director Interviews
Incanthera says development of skin cancer asset Sol has gone 'way beyond any expectations'
Small caps
Incanthera believe new skin cancer prevention cream reveals 'all positives and no negatives'
